Congleton Jon

CIK 00016449752 companiesRADNOR, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001644975

Recent Transactions

35 trades

Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-21$0.54/sh+24,082→ 655,387 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-11-21−24,082→ 0 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$45.20/sh−29,207→ 776,430 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$42.31/sh−8,862→ 809,637 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$46.89/sh−32,850→ 631,305 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$45.83/sh−112,275→ 664,155 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$43.50/sh−4,000→ 805,637 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$41.64/sh−12,806→ 818,499 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-10-13$42.63/sh−13,548→ 832,857 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-10-13$43.03/sh−1,552→ 831,305 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-07-11$14.51/sh−15,884→ 846,405 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-04-11$12.19/sh−15,319→ 862,289 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-02-13+570,000→ 570,000 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-01-13$9.06/sh−18,333→ 877,608 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-10-11$13.52/sh−15,271→ 895,941 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-07-11$13.34/sh−15,746→ 911,212 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-06-20$11.73/sh−14,940→ 926,958 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-06-18$11.99/sh−16,607→ 941,898 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-06-17$12.25/sh−17,766→ 958,505 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-06-14$12.52/sh−16,229→ 976,271 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-06-13$12.74/sh−39,961→ 992,500 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-06-12$12.77/sh−16,607→ 1,032,461 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2024-02-13+425,000→ 425,000 total
Purchase
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2023-11-22$5.97/sh+4,250→ 1,049,068 total
Purchase
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2023-09-06$12.08/sh+2,250→ 1,044,818 total
Purchase
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2023-08-17$12.10/sh+2,250→ 1,042,568 total
Purchase
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2023-08-11$12.89/sh+2,000→ 1,040,318 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2023-03-17+99,800→ 99,800 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2023-02-09+250,046→ 250,046 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to Buy)
2016-09-12+250,000→ 250,000 total
Purchase
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2016-06-16$3.87/sh+5,000→ 20,000 total
Purchase
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2016-03-24$4.22/sh+5,000→ 15,000 total
Purchase
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2016-03-22$4.38/sh+5,000→ 10,000 total
Purchase
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2015-12-11$8.10/sh+5,000→ 5,000 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to Buy)
2015-09-11+121,100→ 121,100 total

Companies

Recent Filings

Address

150 N. RADNOR CHESTER ROAD, SUITE F200

RADNOR, PA, 19087

View on SEC.gov